396 related articles for article (PubMed ID: 16291571)
21. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
[TBL] [Abstract][Full Text] [Related]
22. Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein.
Okumura K; Imamura A; Murakami R; Takahashi R; Cheng XW; Numaguchi Y; Murohara T
Metabolism; 2009 Sep; 58(9):1306-11. PubMed ID: 19501864
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies.
Watts GF; Moroz P; Barrett PH
Metabolism; 2000 Sep; 49(9):1204-10. PubMed ID: 11016905
[TBL] [Abstract][Full Text] [Related]
24. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Dinkel RE; Barrett PH; Demant T; Parhofer KG
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K
Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
[TBL] [Abstract][Full Text] [Related]
27. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
[TBL] [Abstract][Full Text] [Related]
28. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.
Campos H; Walsh BW; Judge H; Sacks FM
J Clin Endocrinol Metab; 1997 Dec; 82(12):3955-63. PubMed ID: 9398695
[TBL] [Abstract][Full Text] [Related]
29. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ
J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
[TBL] [Abstract][Full Text] [Related]
30. Lysine and arginine residues in the N-terminal 18% of apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.
Bakillah A; Jamil H; Hussain MM
Biochemistry; 1998 Mar; 37(11):3727-34. PubMed ID: 9521691
[TBL] [Abstract][Full Text] [Related]
31. The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress.
Zák A; Jáchymová M; Tvrzická E; Vecka M; Duffková L; Zeman M; Slabý A; Stanková B
J Nutr Biochem; 2008 Sep; 19(9):634-41. PubMed ID: 18280132
[TBL] [Abstract][Full Text] [Related]
32. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels.
Karpe F; Lundahl B; Ehrenborg E; Eriksson P; Hamsten A
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):756-61. PubMed ID: 9598834
[TBL] [Abstract][Full Text] [Related]
33. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
[TBL] [Abstract][Full Text] [Related]
34. In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T; Packard C
Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
[TBL] [Abstract][Full Text] [Related]
35. Genetic determinants of apolipoprotein B-100 kinetics.
Ng TW; Ooi EM; Watts GF; Chan DC; Barrett PH
Curr Opin Lipidol; 2010 Apr; 21(2):141-7. PubMed ID: 20154610
[TBL] [Abstract][Full Text] [Related]
36. Effect of microsomal triglyceride transfer protein gene polymorphism in the promoter region on dyslipidemia in type 2 diabetic subjects.
Chen L; Yoshino G; Maeda E; Zeng S
Chin Med J (Engl); 2003 Feb; 116(2):215-7. PubMed ID: 12775233
[TBL] [Abstract][Full Text] [Related]
37. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
[TBL] [Abstract][Full Text] [Related]
38. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J
J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
[TBL] [Abstract][Full Text] [Related]
39. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
[TBL] [Abstract][Full Text] [Related]
40. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
